Skip to main content

$0.315 0.010 (3.28%)

High

$0.32

Low

$0.30

Trades

243

Turnover

$627,825

Volume

2,012,212
30 June 2023 at 4:10pm
Register to track IMM and receive email alerts.
These articles are automatically gathered and therefore may not always be accurate. It is also not possible to guarantee that discovery/publishment dates are accurate.
IMM Media Articles (3 months, all sources, average 0.00 per day)

Latest Media Articles

Site
Immutep MS therapy IMP761 found safe in initial Phase 1 trial data

multiplesclerosisnewstoday.com, discovered 20-Dec at 5:41am

Immutep Announces Initial Safety Data from First-in-Human Phase I Tria...

uk.finance.yahoo.com, discovered 18-Dec at 12:00am

Immutep, Monash Reveal LAG-3 Binding to MHC Class II

miragenews.com, discovered 17-Dec at 3:28pm

Immutep Reveals Promising Data for IMP761 Trial

markets.businessinsider.com, discovered 17-Dec at 9:31am

Immutep and Monash University Announce First Publication Detailing How...

manilatimes.net, discovered 16-Dec at 11:00am

Study Sheds Light on New Ways for Immunotherapy to Better Target Cance...

technologynetworks.com, discovered 16-Dec at 11:00am

Australian research unlocks new path for cancer immunotherapy

news-medical.net, discovered 15-Dec at 1:50pm

Unlocking the potential to better target cancer with immunotherapy

monash.edu, discovered 14-Dec at 11:00am

Immutep shares new cancer study results

ph.investing.com, discovered 13-Dec at 7:43am

Immutep reports positive data in head and neck cancer trial

finnewsnetwork.com.au, discovered 12-Dec at 8:21pm

Immutep Reports Promising New Data In Head And Neck Cancer At ESMO Imm...

menafn.com, discovered 12-Dec at 7:31pm

Immutep’s Promising Trial Results in Cancer Therapy

nasdaq.com, discovered 12-Dec at 9:57am

Immutep begins phase III lung cancer trial

ng.investing.com, discovered 11-Dec at 9:59pm

Immutep launches Phase III trial in lung cancer

sharecafe.com.au, discovered 11-Dec at 4:28am

Immutep Announces Initiation of TACTI-004 Phase III Trial in First Lin...

morningstar.com, discovered 10-Dec at 4:00pm

Is this ASX All Ords stock primed for a takeover offer in 2025?

fool.com.au, discovered 7-Dec at 12:36am

This ASX biotech stock could be the next M&A target

afr.com, discovered 6-Dec at 3:45am

Immutep shares price target raised on study data

investing.com, discovered 15-Nov at 8:12pm

Immutep (NASDAQ:IMMP) Stock, Earnings Estimates, EPS, And Revenue

benzinga.com, discovered 15-Nov at 3:58am

Immutep Limited: Immutep Quarterly Activities Report Q1 FY25

finanznachrichten.de, discovered 30-Oct at 12:06am

Retail therapy: Surprise sales surge

sharecafe.com.au, discovered 1-Oct at 5:51pm

LDC weaves its way to Namoi control

sharecafe.com.au, discovered 1-Oct at 10:00am

CDK 7 Inhibitors Market is Expected to Showcase a Significant Growth b...

prnewswire.co.uk, discovered 26-Sep at 7:30am

Immune Checkpoint Inhibitors Market Surges to USD 168.76 Billion by 20...

prnewswire.co.uk, discovered 26-Sep at 12:09am

Immutep Gets $3.6M R&D Tax Boost from French Gov't

miragenews.com, discovered 25-Sep at 3:44am

Immutep Receives A$3.6 million R&D Tax Incentive from French Governmen...

finance.yahoo.com, discovered 24-Sep at 10:00pm

Immutep recieves R&D tax incentive from France

investing.com, discovered 24-Sep at 9:25pm

Health Check: Experts deliver their verdict on the Healius imaging dea...

stockhead.com.au, discovered 24-Sep at 11:11am

Immutep receives A$3.6 million French R&D Tax Incentive

finnewsnetwork.com.au, discovered 24-Sep at 7:44am

Immutep (ASX:IMM) announces positive results in head and neck cancer t...

finnewsnetwork.com.au, discovered 23-Sep at 5:58am

The 7 biotech stocks (and their trials) these experts are watching rig...

livewiremarkets.com, discovered 20-Sep at 9:54am

$11M Awarded Under ARC's Discovery Indigenous Scheme

miragenews.com, discovered 19-Sep at 9:11pm

Evening Wrap: ASX 200 notches new record on surging mining and energy ...

marketindex.com.au, discovered 19-Sep at 5:41pm

New Data to be Presented from EFTISARC-NEO Phase II Evaluating Novel T...

biospace.com, discovered 18-Sep at 10:00am

Immutep reports positive results in cancer study

ph.investing.com, discovered 18-Sep at 8:57am

Riding high on ESMO data, Nuvalent reaps $500M in offering

bioworld.com, discovered 18-Sep at 4:21am

Immutep’s Efti in Combination with MSD’s KEYTRUDA® Leads to Positive E...

markets.businessinsider.com, discovered 16-Sep at 6:00pm

‘Full steam ahead’: Aussie shares close at record high

aap.com.au, discovered 16-Sep at 5:24pm

Immutep's Efti in Combination with MSD's KEYTRUDA® Leads to Positive E...

tmcnet.com, discovered 16-Sep at 10:00am

Alive and Kicking: Respiri promises breath of life to bottom line afte...

stockhead.com.au, discovered 16-Sep at 10:00am

Immutep joins S&P/ASX indices after quarterly rebalance

ng.investing.com, discovered 11-Sep at 1:18am

Immutep Quarterly Activities Report Q4 FY24

markets.businessinsider.com, discovered 31-Jul at 10:51pm

Clinical trials in cancer and autoimmune diseases: Immutep’s CEO Marc ...

sharecafe.com.au, discovered 30-Jul at 5:52pm

Immutep mulls filings for LAG-3 drug after new readout

pharmaphorum.com, discovered 29-Jul at 10:00am

Potential MS therapy IMP761 to be tested in healthy volunteers

multiplesclerosisnewstoday.com, discovered 25-Jul at 2:59pm

Market Highlights: CrowdStrike plunges 11pc after global outage, as Bi...

couriermail.com.au, discovered 25-Jul at 7:34am

ASX reporting season calendar August 2024

marketindex.com.au, discovered 24-Jul at 4:37pm

Immutep advances with FDA for Phase III lung cancer trial

uk.investing.com, discovered 24-Jul at 12:40am

Immutep Limited: Immutep Announces Successful Meeting with FDA on Phas...

finanznachrichten.de, discovered 22-Jul at 11:30pm

Immutep Announces Successful Meeting With FDA On Phase III Design In N...

menafn.com, discovered 22-Jul at 6:17pm

Register to track IMM and receive email alerts.